Cargando…

Soluble ST2 in the prediction of heart failure and death in patients with atrial fibrillation

BACKGROUND: Biomarkers may be a useful marker for predicting heart failure (HF) or death in patients with atrial fibrillation (AF). HYPOTHESIS: Soluble ST2 (sST2) may be a good biomarker for the prediction of HF or death in patients with AF. METHODS: This is a prospective study of patients with nonv...

Descripción completa

Detalles Bibliográficos
Autores principales:	Krittayaphong, Rungroj, Pumprueg, Satchana, Sairat, Poom
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Clinical Investigations
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019881/ https://www.ncbi.nlm.nih.gov/pubmed/35188278 http://dx.doi.org/10.1002/clc.23799

Ejemplares similares

Average Systolic Blood Pressure and Clinical Outcomes in Patients with Atrial Fibrillation: Prospective Data from COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Impact of anemia on clinical outcomes of patients with atrial fibrillation: The COOL‐AF registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Left Atrial Diameter in the Prediction of Thromboembolic Event and Death in Atrial Fibrillation
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Predicting Heart Failure in Patients with Atrial Fibrillation: A Report from the Prospective COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

Efficacy of R(2)CHA(2)DS(2)-VA score for predicting thromboembolism in Thai patients with non-valvular atrial fibrillation
por: Methavigul, Komsing, et al.
Publicado: (2021)

Age-Related Clinical Outcomes of Patients with Non-Valvular Atrial Fibrillation: Insights from the COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Predicting the Absolute Risk of Ischemic Stroke in Asian Patients with Atrial Fibrillation: Comparing the COOL-AF Risk Score with CARS/mCARS Models for Absolute Risk and the CHA2DS2-VASc Score
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

The Rate of Clinical Outcomes in Atrial Fibrillation according to Antithrombotic Strategy: The COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2022)

Poor Time in Therapeutic Range Control is Associated with Adverse Clinical Outcomes in Patients with Non-Valvular Atrial Fibrillation: A Report from the Nationwide COOL-AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2020)

Altered profile of circulating microparticles in nonvalvular atrial fibrillation
por: Siwaponanan, Panjaree, et al.
Publicado: (2019)

Increased small extracellular vesicle levels and decreased miR‐126 levels associated with atrial fibrillation and coexisting diabetes mellitus
por: Siwaponanan, Panjaree, et al.
Publicado: (2023)

Causes of death of patients with non-valvular atrial fibrillation in Asians
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

Impact of different degrees of left ventricular strain on left atrial mechanics in heart failure with preserved ejection fraction
por: Songsangjinda, Thammarak, et al.
Publicado: (2022)

Outcomes and factors associated with mortality in patients with atrial fibrillation and heart failure: FARAONIC study
por: Gómez Doblas, Juan José, et al.
Publicado: (2023)

Ventricular rate in atrial fibrillation and the risk of heart failure and death
por: Westergaard, Lucas Malta, et al.
Publicado: (2023)

Mortality risk and temporal patterns of atrial fibrillation in the nationwide registry
por: Apiyasawat, Sirin, et al.
Publicado: (2021)

Catheter ablation of atrial fibrillation in patients with heart failure and preserved ejection fraction: A meta‐analysis
por: Gu, Gaoyang, et al.
Publicado: (2022)

Associations of anemia with death and major bleeding in patients with atrial fibrillation: A report from the Chinese Atrial Fibrillation Registry Study
por: Zhang, Zhuxin, et al.
Publicado: (2021)

Relationship between device‐detected subclinical atrial fibrillation and heart failure in patients with cardiac resynchronization therapy defibrillator
por: Arai, Shuhei, et al.
Publicado: (2020)

Predictive value of HMGB1 for atrial fibrillation recurrence after cryoballoon ablation in paroxysmal atrial fibrillation patients
por: Li, Xinxin, et al.
Publicado: (2022)

Incidence of atrial fibrillation, ischaemic heart disease and heart failure in patients with diabetes
por: Groenewegen, Amy, et al.
Publicado: (2021)

Are the atrial natriuretic peptides a missing link predicting low‐voltage areas in atrial fibrillation? Introducing the novel biomarker‐based atrial fibrillation substrate prediction (ANP) score
por: Seewöster, Timm, et al.
Publicado: (2020)

Efficacy and safety outcomes of patients with atrial fibrillation compared between warfarin and non-vitamin K antagonist oral anticoagulants based on SAMe-TT(2)R(2) score
por: Methavigul, Komsing, et al.
Publicado: (2023)

Cost-Utility Analysis of Sacubitril-Valsartan Compared with Enalapril Treatment in Patients with Acute Decompensated Heart Failure in Thailand
por: Krittayaphong, Rungroj, et al.
Publicado: (2021)

Impact of Achieving Blood Pressure Targets and High Time in Therapeutic Range on Clinical Outcomes in Patients With Atrial Fibrillation Adherent to the Atrial Fibrillation Better Care Pathway: A Report From the COOL‐AF Registry
por: Krittayaphong, Rungroj, et al.
Publicado: (2023)

Assessing left atrial function in patients with atrial fibrillation and valvular heart disease using cardiovascular magnetic resonance imaging
por: Hou, Jie, et al.
Publicado: (2022)

The predictive value of changes in left atrial volume index for rehospitalization in heart failure with preserved ejection fraction
por: Hao, Zhujing, et al.
Publicado: (2022)

Characteristics and antithrombotic treatment patterns of patients with concomitant coronary artery disease and atrial fibrillation from Thailand’s COOL-AF registry
por: Winijkul, Arjbordin, et al.
Publicado: (2021)

Outcome disparities in patients with atrial fibrillation based on insurance plan and educational attainment: a nationwide, multicenter and prospective cohort trial
por: Apiyasawat, Sirin, et al.
Publicado: (2022)

Biatrial volume ratio predicts low voltage areas in atrial fibrillation
por: Seewöster, Timm, et al.
Publicado: (2021)

Impaired fasting glucose: a risk factor for atrial fibrillation and heart failure
por: Lind, Viktor, et al.
Publicado: (2021)

Cost-Effectiveness Analysis of the Adjunctive Therapy of Ivabradine for the Treatment of Heart Failure with Reduced Ejection Fraction
por: Krittayaphong, Rungroj, et al.
Publicado: (2019)

Stroke Prevention in Atrial Fibrillation: A Scientific Statement of JACC: Asia (Part 2)
por: Chiang, Chern-En, et al.
Publicado: (2022)

Prevalence of atrial fibrillation dependent on coronary artery status: Insights from the LIFE‐Heart Study
por: Kornej, Jelena, et al.
Publicado: (2020)

Left atrial appendage size is a marker of atrial fibrillation recurrence after radiofrequency catheter ablation in patients with persistent atrial fibrillation
por: Simon, Judit, et al.
Publicado: (2021)

Serum-Soluble ST2 Is a Novel Biomarker for Evaluating Left Atrial Low-Voltage Zone in Paroxysmal Atrial Fibrillation
por: Wang, Zefeng, et al.
Publicado: (2020)

Defibrillation threshold of internal cardioversion prior to ablation predicts atrial fibrillation recurrence
por: Sawasaki, Kohei, et al.
Publicado: (2021)

The impact of catheter ablation for atrial fibrillation in heart failure
por: Moschonas, Konstantinos, et al.
Publicado: (2018)

Rhythm Control in Heart Failure Patients with Atrial Fibrillation
por: Eysenck, William, et al.
Publicado: (2020)

Mode of death in elderly and super‐elderly patients with acute heart failure: Insights from Japanese heart failure registry
por: Takabayashi, Kensuke, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vfkbpen4rmnhq6272440ks0hvs